ypfM Antibody
Description
Biological Context of ypfM Protein
ypfM is a small protein (typically <100 amino acids) implicated in bacterial stress adaptation. Key findings include:
-
Regulation: ypfM expression is weakly associated with heat shock response pathways, though no strong regulatory binding sites (e.g., σ<sup>32</sup>) have been identified upstream .
-
Stress Induction: Experimental data show ypfM is minimally induced during heat shock (≤2-fold) compared to other small proteins like YkgR or YobF .
-
Operon Structure: ypfM is not part of a characterized operon, suggesting independent regulation or context-dependent functionality .
Antibody Applications in ypfM Research
Antibodies are critical for detecting ypfM in experimental workflows. While no commercial ypfM-specific antibodies are documented, methodologies from analogous studies include:
Immunoblot Assays
-
Tagged Constructs: Researchers often fuse ypfM with epitope tags (e.g., FLAG, SPA) for detection using anti-tag monoclonal antibodies .
-
Example Protocol:
Key Challenges in Antibody Validation
-
Specificity: Antibodies must distinguish ypfM from other small proteins in complex lysates .
-
Reproducibility: Variability in antibody performance across assays (e.g., Western blot vs. immunofluorescence) necessitates rigorous validation .
Broader Implications for Antibody Development
-
Antigen Design: Generating ypfM-specific antibodies requires high-purity recombinant antigens to ensure epitope specificity .
-
Validation Standards: Initiatives like the Antibody Society’s Therapeutic Antibody Database emphasize the need for standardized characterization (e.g., target binding, cross-reactivity assays) .
Future Directions
-
Proteome-Wide Studies: Large-scale efforts (e.g., YCharOS) aim to map antibody performance across diverse proteins, which could include ypfM in future iterations .
-
Therapeutic Potential: Engineered antibodies targeting bacterial stress proteins like ypfM may offer novel antimicrobial strategies, though this remains exploratory .
Product Specs
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Target Background
KEGG: eco:b4606
STRING: 511145.b4606
Q&A
What are the common aliases and identifiers for YopM?
When conducting literature searches or database queries, researchers should be aware of several aliases for YopM:
Recognizing these alternative designations ensures comprehensive coverage of relevant research when performing literature reviews.
What types of YopM antibodies are available for research applications?
Several types of antibodies targeting YopM are available for research:
The YCharOS study demonstrated that recombinant antibodies outperformed both monoclonal and polyclonal antibodies on average in all assays tested, which has significant implications for antibody selection .
How should YopM antibody specificity be validated before experimental use?
Proper validation is critical for experimental reproducibility. Based on findings from the antibody characterization field, researchers should:
-
Use knockout (KO) cell lines as negative controls when possible, as these have been shown to be superior to other types of controls, especially for Western blots and immunofluorescence imaging .
-
Perform concentration gradient tests to determine optimal working conditions (as shown in the Western blot data for ab225950, which tested various amounts of recombinant protein) .
-
Verify antibody specificity using:
-
Positive controls (samples known to express YopM)
-
Blocking peptides or competition assays
-
Multiple antibodies targeting different epitopes of the same protein
-
-
Check if the antibody has been independently characterized by initiatives like YCharOS, which has evaluated hundreds of antibodies for specificity and functionality .
The YCharOS study revealed that an average of ~12 publications per protein target included data from antibodies that failed to recognize their relevant target protein , underscoring the critical importance of thorough validation.
What are the optimal conditions for Western blot using YopM antibodies?
Based on the Western blot protocol information available for ab225950 :
| Parameter | Recommended Condition |
|---|---|
| Antibody dilution | 1/500 |
| Secondary antibody | Goat polyclonal to rabbit IgG |
| Secondary antibody dilution | 1/50000 |
| Detection method | ECL (Enhanced Chemiluminescence) |
| Protein amounts tested | 10-80 ng of recombinant protein |
These conditions provided successful detection of YopM in Western blot analysis. The protocol tested multiple concentrations (10, 20, 40, and 80 ng) of recombinant protein, demonstrating the importance of using concentration gradients in validation .
How can cross-reactivity issues with YopM antibodies be addressed?
Cross-reactivity can compromise experimental results. Researchers should:
-
Test antibody reactivity against related bacterial proteins, particularly from other Yersinia species or closely related bacteria.
-
Consider sequence homology when evaluating potential cross-reactivity - antibody vendors may provide predictions based on sequence analysis .
-
Include appropriate controls from related bacteria to assess cross-reactivity experimentally.
-
When possible, use recombinant antibodies, which the YCharOS study found to typically have better specificity than polyclonal antibodies .
-
Implement absorption controls where the antibody is pre-incubated with purified antigen before use.
How does YopM contribute to Yersinia pestis pathogenesis?
YopM is part of a sophisticated virulence mechanism of Y. pestis. Research indicates multiple potential functions:
-
Initially, YopM was thought to function primarily by binding human α-thrombin tightly enough to prevent platelet activation . This interaction was believed to occur extracellularly, with YopM sequestering thrombin as it's generated from prothrombin at infection sites .
-
The anti-inflammatory effect of this mechanism was hypothesized to contribute to Y. pestis virulence, consistent with findings that YopM is necessary for full virulence in mice .
-
Research questioned whether thrombin-binding is YopM's main function during infection and investigated whether YopM remains extracellular or is targeted into phagocytes like other Yersinia secreted proteins .
-
YopM does not bind prothrombin, suggesting a selective interaction with activated thrombin rather than its precursor .
These complex interactions make YopM an important subject for researchers studying host-pathogen interactions and developing potential therapeutic interventions.
What role does YopM play in vaccine development research?
YopM has been investigated as a potential component for plague vaccines, but research indicates important limitations:
-
YopM is highly immunogenic in mice and human convalescent plague sera contain antibodies to YopM .
-
Despite this immunogenicity, YopM is not considered a good candidate for a subunit plague vaccine based on protection studies .
-
Research evaluated several aspects of YopM as a potential vaccine component, including:
-
Immunogenicity and protective capacity
-
Whether anti-YopM antibodies provide significant protection against lethal Y. pestis challenge
-
The quality of humoral anti-YopM response following different immunization routes and adjuvants
-
-
In protection studies, the LD50 in YopM-immunized mice was not significantly different from the PBS-treated control group following Y. pestis challenge, suggesting that despite being immunogenic, antibodies against YopM may not confer significant protection .
These findings have important implications for plague vaccine development strategies and highlight the complexity of protective immunity against Y. pestis.
How can researchers distinguish between different functional domains of YopM?
To investigate domain-specific functions of YopM, researchers could employ:
-
Domain-specific antibodies that recognize particular regions of the YopM protein.
-
Mutational analysis approaches, as mentioned in the research where "a set of mutant yopM genes" were created to study thrombin-binding characteristics and virulence .
-
Structural biology approaches combined with immunological techniques to map the relationship between structure and function.
-
Expression of truncated versions of YopM to isolate individual domains and their functions.
The research described in search result specifically used mutant YopM proteins to characterize thrombin-binding and tested Y. pestis strains carrying these mutant yopMs for virulence in mice, demonstrating a methodological approach to investigate domain-specific functions.
What methodological approaches are recommended for studying YopM localization during infection?
Understanding YopM localization is crucial for elucidating its function. Recommended approaches include:
-
Immunofluorescence microscopy: Using validated anti-YopM antibodies to visualize the protein's location in infected cells or tissues. The YCharOS study emphasized the importance of knockout controls especially for immunofluorescence applications .
-
Subcellular fractionation: Separating cellular components (cytoplasm, membrane, nucleus) followed by Western blot analysis to determine which fraction contains YopM.
-
Co-localization studies: Combining anti-YopM antibodies with markers for specific cellular compartments to determine precise localization.
-
Cell infection models: Establishing appropriate infection models with Y. pestis and host cells (particularly phagocytes, given the research questions in search result ).
The research question in Aim 3 of the study in search result specifically addressed whether YopM is secreted to the medium or into phagocytes when Y. pestis contacts a macrophage, highlighting the importance of methodologies that can distinguish between extracellular and intracellular pools of the protein.
What are common issues when using YopM antibodies and how can they be addressed?
While the search results don't specifically address troubleshooting for YopM antibodies, we can apply general principles from antibody characterization research :
The YCharOS study highlighted that ~20% of tested antibodies failed to meet expectations, and vendors modified the proposed applications for ~40% of antibodies after evaluation . This underscores the importance of thorough validation and troubleshooting.
How can researchers evaluate whether a YopM antibody is suitable for their specific strain or isolate of Yersinia?
To determine if a YopM antibody will recognize the YopM protein from a specific Yersinia strain:
-
Sequence analysis: Compare the YopM sequence of your strain to the immunogen used to generate the antibody. The ab225950 antibody was generated against recombinant full-length YopM protein from Yersinia pestis .
-
Preliminary testing: Validate the antibody using positive controls from your specific strain alongside known positive controls.
-
Western blot analysis: Run protein extracts from your strain alongside recombinant YopM or extracts from reference strains.
-
Consider cross-reactivity: Some antibodies may recognize YopM from multiple Yersinia species due to conserved epitopes .
-
Manufacturer consultation: Contact the antibody manufacturer with your specific strain information to inquire about expected reactivity.
How might advances in antibody characterization impact YopM research?
The antibody characterization initiatives described in search result have significant implications for YopM research:
What are the current gaps in understanding YopM function that improved antibodies could help address?
Several knowledge gaps about YopM could be addressed with improved antibodies:
-
Intracellular vs. extracellular localization: The study in search result sought to determine whether YopM is extracellular, delivered into phagocytes, or both. High-specificity antibodies for immunofluorescence could help resolve this question.
-
Functions beyond thrombin-binding: The study described in search result questioned whether thrombin-binding is YopM's main function during infection. Antibodies that can specifically block different domains of YopM could help elucidate additional functions.
-
Interaction partners: Beyond α-thrombin, YopM may interact with other host proteins. Co-immunoprecipitation using validated YopM antibodies could help identify these partners.
-
Structural conformations: YopM may adopt different conformations in different contexts. Conformation-specific antibodies could help investigate this possibility.
Addressing these gaps would contribute to a more comprehensive understanding of Y. pestis pathogenesis and potentially inform new therapeutic approaches.
